A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Journal of Evidence Based Medicine and Healthcare
BACKGROUND Anticardiolipin antibodies (aCL) have been recognized as an independent risk factor for an increased risk of thrombosis. The aim of our study was to assess the prevalence of aCL antibodies in patients with CVT (Cerebral Venous Thrombosis) and correlate clinical profile of CVT with anticardiolipin antibody titre. METHODS Forty-two patients with CVT diagnosed by neuroimaging were investigated for the presence of aCL. We compared the clinical profile of ACL antibody positive anddoi:10.18410/jebmh/2020/538 fatcat:5zu747tbl5fjppcck6jjw4phza